The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...

The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...